Kinetic analysis and comparison of uptake, distribution, and excretion of 48V-labeled compounds in rats

Journal of Applied Physiology

Volumn 84, Issue 2, 1998, Pages 569-575

  Setyawati, I A ^a   Thompson, K H ^a   Yuen, V G ^a   Sun, Y ^a   Battell, M ^a   Lyster, D M ^a   Vo, C ^a   Ruth, T J ^b   Zeisler, S ^b   McNeill, J H ^a   Orvig, C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b TRIUMF   (Canada)

Author keywords

Compartmental modeling; Diabetes; Insulin mimetic; Simulation, analysis, and modeling software; Vanadium

Indexed keywords

DRUG CARRIER; FERRIC MALTOL; GLUCOSE; MALTOL; VANADIUM DERIVATIVE; VANADYL SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARTMENT MODEL; COMPUTER MODEL; COMPUTER SIMULATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG TISSUE LEVEL; DRUG UPTAKE; GLUCOSE BLOOD LEVEL; INTRAPERITONEAL DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0031915261     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/jappl.1998.84.2.569     Document Type: Article

References (43)

1. Al-Bayati, M., O. G. Raabe, S. N. Giri, and J. B. Knaak. Distribution of vanadate in the rat following subcutaneous and oral routes of administration. J. Am. Coll. Toxicol. 10: 233-241, 1991.
2. Barrand, M. A., and B. A. Callingham. Evidence for regulatory control of iron uptake from ferric maltol across the small intestine of the rat. Br. J. Pharmacol. 102: 408-414, 1991.
3. Barrand, M. A., B. A. Callingham, P. Dobbin, and R. C. Hider. Dissociation of a ferric maltol complex and its subsequent metabolism during absorption across the small intestine of the rat. Br. J. Pharmacol. 102: 723-729, 1991.
4. Berman, M., and M. F. Weiss. SAAM Manual. Washington, DC: Department of Health, Education, and Welfare, 1978.
5. Berman, M., M. F. Weiss, and E. Shahn. Some formal approaches to the analysis of kinetic data in terms of linear compartmental systems. Biophys. J. 2: 289-315, 1962.
6. Bogden, J. D., H. Higashino, M. A. Lavenhar, J. W. Bauman, Jr., F. W. Kemp, and A. Aviv. Balance and tissue distribution of vanadium after short-term ingestion of vanadate. J. Nutr. 112: 2279-2285, 1982.
7. Caravan, P., L. Gelmini, N. Glover, F. G. Herring, H. Li, J. H. McNeill, S. J. Rettig, I. A. Setyawati, E. Shuter, Y. Sun, A. S. Tracey, V. G. Yuen, and C. Orvig. Reaction chemistry of BMOV, bis(maltolato)oxovanadium(IV), a potent insulin mimetic agent. J. Am. Chem. Soc. 117: 12759-12770, 1995.
8. Chasteen, N. D. The biochemistry of vanadium. Struct. Bond. (Berlin) 53: 105-138, 1983.
9. Clark, A. S., J. M. Fagan, and W. E. Mitch. Selectivity of the insulin-like actions of vanadate on glucose and protein metabolism in skeletal muscle. Biochem. J. 232: 273-276, 1985.
10. Cohen, N., M. Halberstam, P. Shlimovich, C. J. Chang, H. Shamoon, and L. Rossetti. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with noninsulin-dependent diabetes mellitus. J. Clin. Invest. 95: 2501-2509, 1995.
11. Conklin, A. W., C. S. Skinner, T. L. Felten, and C. L. Sanders. Clearance and distribution of intratracheally instilled 48-vanadium compounds in the rat. Toxicol. Lett. 11: 199-203, 1982.
12. Dai, S., K. H. Thompson, and J. H. McNeill. One year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate. Pharmacol. Toxicol. 74: 101-109, 1994.
13. Dai, S., V. G. Yuen, C. Orvig, and J. H. McNeill. Prevention of diabetes-induced pathology in STZ-rats by bis(maltolato)oxovanadium (IV). Pharmacol. Commun. 3: 311-321, 1993.
14. DiStefano, J. J., and E. M. Landaw. Multiexponential, multicompartmental, and noncompartmental modeling. I. Methodological limitations and physiological interpretations. Am. J. Physiol. 246 (Regulatory Integrative Comp. Physiol. 15): R651-R664, 1984.
15. Dubyak, G. R., and A. Kleinzeller. The insulin-mimetic effects of vanadate in isolated rat adipocyctes. J. Biol. Chem. 255: 5306-5312, 1980.
16. Duckworth, W. C., S. S. Solomon, J. Liepnieks, F. G. Hamel, S. Handand, and D. E. Peavy. Insulin-like effects of vanadate in isolated rat adipocytes. Endocrinology 122: 2285-2289, 1988.
17. Goldfine, A. B., D. C. Simonson, F. Folli, M.-E. Patti, and C. R. Kahn. Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 80: 3311-3320, 1995.
18. Hamel, F. G., and W. C. Duckworth. The relationship between insulin and vanadium metabolism in insulin target tissues. Mol. Cell. Biochem. 153: 95-102, 1995.
19. Henquin, J. C., and S. M. Brichard. Place du vanadium dans le traitement du diabete. Donnees experimentales et applications cliniques. La Presse Medicale 21: 1100-1101, 1992.
20. Heyliger, C. E., A. G. Tahiliani, and J. H. McNeill. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science 227: 1474-1477, 1985.
21. Hopkins, L. L., Jr., and B. E. Tilton. Metabolism of trace amounts of vanadium-48 in rat organs and liver subcellular particles. Am. J. Physiol. 211: 169-172, 1966.
22. Jacquez, J. A. Compartmental Analysis in Biology and Medicine (2nd ed.). Ann Arbor, MI: University of Michigan Press, 1985.
23. Levey, J. A., M. A. Barrand, B. A. Callingham, and R. C. Hider. Characteristics of iron(III) uptake by isolated fragments of rat small intestine in the presence of the hydroxypyrones, maltol and ethyl maltol. Biochem. Pharmacol. 37: 2051-2057, 1988.
24. Maddalena, D. J. TISCON, a basic computer program for the calculation of the biodistribution of radionuclide-labelled drugs in rats and mice. Lucas Heights, Australia: Australian Atomic Energy Commission, 1983.
25. McNeill, J. H., V. G. Yuen, H. R. Hoveyda, and C. Orvig. Bis(maltolato)oxovanadium(IV) is a potent insulin mimic. J. Med. Chem. 35: 1489-1491, 1992.
26. Nielsen, F. H. Vanadium in mammalian physiology and nutrition. In: Vanadium and Its Role in Life, edited by H. Sigel and A. Sigel. New York: Dekker, 1995, vol. 31, p. 543-574. (Metal Ions Biol. Syst. Ser.)
27. Orvig, C., K. H. Thompson, M. Battell, and J. H. McNeill. Vanadium compounds as insulin mimics. Met. Ions Biol. Syst. 31: 575-594, 1995.
28. Patterson, B. W., S. L. Hansard II, C. B. Ammerman, P. R. Henry, L. A. Zech, and W. R. Fisher. Kinetic model of whole body vanadium metabolism: studies in sheep. Am. J. Physiol. 251 (Regulatory Integrative Comp. Physiol. 20): R325-R332, 1986.
29. Posner, B. I., A. Shaver, and I. G. Fantus. Insulin mimetic agents: vanadium and peroxovanadium compounds. In: New Antidiabetic Drugs, edited by C. J. Bailey and P. R. Flatt. London: Smith-Gordon Publishing, 1990, p. 107-118.
30. Ramasarma, T., and F. L. Crane. Does vanadium play a role in cellular regulation? Curr. Top. Cell. Regul. 20: 247-301, 1981.
31. Sabbioni, E., and E. Marafante. Metabolic patterns of vanadium in the rat. Bioinorg. Chem. 9: 389-407, 1978.
32. Sabbioni, E., E. Marafante, L. Amantini, L. Ubertalli, and C. Birattari. Similarity in metabolic patterns of different chemical species of vanadium in the rat. Bioinorg. Chem. 8: 503-515, 1978.
33. Shechter, Y. Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes. Diabetes 39: 1-5, 1990.
34. Shechter, Y., and S. J. D. Karlish. Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions. Nature 284: 556-558, 1980.
35. Shechter, Y., J. Meyerovitch, Z. Farfel, J. Sack, R. Bruck, S. Bar-Meir, S. Amir, H. Degani, and S. J. D. Karlish. Insulin mimetic effects of vanadium. In: Vanadium in Biological Systems, edited by N. D. Chasteen. Dordrecht, The Netherlands: Kluwer, 1990, p. 129-142.
36. Shechter, Y., and A. Ron. Effect of depletion of phosphate and bicarbonate ions on insulin action in rat adipoctyes. J. Biol. Chem. 261: 14945-14950, 1986.
37. Thompson, K. H., K. C. Scott, and J. R. Turnlund. Molybdenum metabolism in men with increasing molybdenum intakes: changes in kinetic parameters. J. Appl. Physiol. 81: 1404-1409, 1996.
38. Thompson, K. H., and J. R. Turnlund. Kinetic model of molybdenum metabolism developed from dual stable isotope excretion in men consuming a low molybdenum diet. J. Nutr. 126: 963-972, 1996.
39. Tolman, E. L., E. Barris, M. Burns, A. Pansisni, and R. Partridge. Effects of vanadium on glucose metabolism in vitro. Life Sci. 25: 1159-1164, 1979.
40. 3. J. Toxicol. Environ. Health 10: 233-245, 1982.
41. Yuen, V. G., C. Orvig, and J. H. McNeill. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration. Can. J. Physiol. Pharmacol. 73: 55-64, 1995.
42. Yuen, V. G., C. Orvig, K. H. Thompson, and J. H. McNeill. Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV). Can. J. Physiol. Pharmacol. 71: 270-276, 1993.
43. 2+ for biomedical studies. J. Radioanal. Nucl. Chem. 200: 283-290, 1995.